id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3472 R13239 |
Bérard, 2019 | Major malformations | 1st trimester | population based cohort propective | unexposed (general population or NOS) | Adjustment: Yes | 1.27 [1.03;1.57] | 105/958 14,402/179,106 | 14,507 | 958 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3267 R13242 |
Huybrechts, 2018 | Any congenital malformations | 1st trimester | retrospective cohort (claims database) | exposed to other treatment, sick | Adjustment: Yes | 1.01 [0.95;1.06] | 1,732/52,809 2,891/77,165 | 4,623 | 52,809 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2404 R13238 |
Ashkenazi-Hoffnung, 2013 | Congenital malformations (NOS) | at least 1st trimester | prospective cohort | exposed to other treatment, sick | Adjustment: No | 3.00 [0.12;77.03] C | 1/28 0/27 | 1 | 28 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2397 R13245 |
Pasternak, 2013 | Major malformations | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 0.93 [0.86;1.02] | 721/28,486 3,024/113,968 | 3,745 | 28,486 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2395 R13243 |
Matok, 2009 | Major malformations | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 1.04 [0.89;1.21] | 182/3,458 3,834/78,245 | 4,016 | 3,458 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2751 R14423 |
Asker, 2005 | Congenital malformations | during pregnancy (anytime or not specified) excluded | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes |
0.81 [0.58;1.13] excluded (exposition period) |
36/1,166 23,745/676,198 | 23,781 | 1,166 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2726 R3600 |
Bsat, 2003 | Anomalies (NOS) | 1st trimester | randomized controlled trial | exposed to other treatment, sick | Adjustment: Randomisation Co-administration | 0.96 [0.02;49.43] C | 0/54 0/52 | 0 | 54 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2393 R13241 |
Berkovitch, 2002 | Major malformations | 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No Matched | 0.91 [0.34;2.45] | 7/158 8/164 | 15 | 158 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2407 R3063 |
Sorensen, 2000 | Malformations (740.00-759.99 (ICD 8) and Q0.0-Q99.9 (ICD 10)). | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 1.11 [0.60;2.06] | 11/190 697/13,327 | 708 | 190 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 8 studies | 1.01 [0.95;1.07] | 27,615 | 86,141 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
Asymetry test p-value = 0.4084 (by Egger's regression)
slope=-0.0190 (0.0337); intercept=0.4823 (0.5427); t=0.8886; p=0.4084
excluded